Research Article

Association of Preoperative Biliary Drainage with Postoperative Morbidity after Pancreaticoduodenectomy

Table 4

Clinical characteristics of 94 matched patients.

PBD ()No-PBD () value

Mean age (years)59 ± 261 ± 10.363
Gender (male)28 (59.6%)19 (40.4%)0.121
Smoking pack-years (>20)10 (21.3%)16 (34.0%)0.249
Hypertension8 (17.0%)10 (21.3%)0.794
Cardiovascular disease1 (2.1%)4 (8.7%)0.160
Diabetes mellitus3 (6.4%)7 (15.2%)0.169
White blood cells (×109/L)7.2 ± 0.56.3 ± 0.40.188
Hemoglobin (g/L)121.5 ± 2.7122.0 ± 1.70.873
Platelet count (×109/L)201.3 ± 11.2195.0 ± 9.00.663
Total bilirubin (μmol/L)363.2 ± 18.0324.90 ± 13.140.090
Alanine aminotransferase (U/L)91.1 ± 11.8103.8 ± 10.50.420
Aspartate aminotransferase (U/L)73.6 ± 8.081.0 ± 7.20.497
Albumin (g/L)38.3 ± 0.937.2 ± 0.60.318
Prothrombin time (s)12.9 ± 0.212.5 ± 0.20.137
Fibrinogen (g/L)4.1 ± 0.24.3 ± 0.20.387
Carcinoembryonic antigen (ng/mL)3.8 ± 0.44.9 ± 3.10.086
Carbohydrate antigen 125 (U/mL)19.6 ± 3.144.2 ± 20.80.182
Carbohydrate antigen 19-9 (U/mL)1062.5 ± 570.6467.0 ± 165.60.342
Blood loss (mL)463.8 ± 52.5412.8 ± 39.40.439
Pathological diagnosis0.806
 Benign disease2 (4.3%)1 (2.1%)
 Malignant carcinoma45 (95.7%)46 (97.9%)
Tumor diameter (cm)3.5 ± 0.23.3 ± 0.20.682